Matt Horas, Asa
About Matt Horas, Asa
Matt Horas is an Actuarial Assistant at Transamerica with a background in actuarial analysis and financial risk management. He has contributed to product launches and automation efforts, and holds a Bachelor's degree in Actuarial Science and Finance from Drake University.
Work at Transamerica
Matt Horas currently serves as an Actuarial Assistant at Transamerica, a position he has held since 2020 in Plano, Texas. Prior to this role, he worked as an Actuarial Analyst from 2018 to 2020 and as an Actuarial Student from 2017 to 2018. During his time at Transamerica, he has led initiatives such as the soft launch of a new Critical Illness product, which resulted in significant sales. He is also recognized as a subject matter expert and case pricing lead for Critical Illness, Short-Term Disability, and Cancer group health lines.
Education and Expertise
Matt Horas holds a Bachelor's degree in Actuarial Science and Finance from Drake University, where he studied from 2013 to 2017. His educational background has equipped him with the necessary skills and knowledge to excel in the actuarial field. Additionally, he attended St. Louis University High from 2009 to 2013, further laying the foundation for his academic and professional pursuits.
Background
Before joining Transamerica, Matt gained valuable experience through various internships and roles. He worked as an Actuarial Intern at Milliman in 2016, focusing on Financial Risk Management, and held similar positions at EMC Insurance Companies and GuideOne Insurance in 2015. These experiences contributed to his understanding of actuarial practices and financial analysis.
Achievements
Matt Horas has led significant projects during his career, including the soft launch of a Critical Illness product that generated over 65 quotes and 8 sold groups, amounting to an expected annual production of $3.5 million. He is also leading an effort to automate the quoting process for smaller groups, which aims to enhance efficiency by freeing up 25% of his team's time. Additionally, he has analyzed and presented the results of the 2020 Annual Assumption Update for Critical Illness and Cancer products.